Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (381-390 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|June 12, 2009
Heritable T-cell malignancy models established in a zebrafish phenotypic screenJ K Frazer, N D Meeker, L Rudner, et al.
Leukemia|June 12, 2009
Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myelomaD Gutman, A A Morales, L H Boise
Leukemia|February 27, 2009
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individualsY Lecluse, P Lebailly, S Roulland, et al.
Leukemia|April 24, 2009
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?T Ripperger, D Steinemann, G Göhring, et al.
Leukemia|December 21, 2011
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?M Z Ratajczak, M Kucia, T Jadczyk, et al.
Leukemia|December 21, 2011
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cellsJ Congleton, R MacDonald, A Yen
Leukemia|December 21, 2011
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortiumA Martino, D Campa, G Buda, et al.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.
Leukemia|March 1, 2012
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxinR Parameswaran, M Yu, M-A Lyu, et al.
Pageof 1,398

Showing results (381-390 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|June 12, 2009
Heritable T-cell malignancy models established in a zebrafish phenotypic screenJ K Frazer, N D Meeker, L Rudner, et al.
Leukemia|June 12, 2009
Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myelomaD Gutman, A A Morales, L H Boise
Leukemia|February 27, 2009
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individualsY Lecluse, P Lebailly, S Roulland, et al.
Leukemia|April 24, 2009
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?T Ripperger, D Steinemann, G Göhring, et al.
Leukemia|December 21, 2011
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?M Z Ratajczak, M Kucia, T Jadczyk, et al.
Leukemia|December 21, 2011
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cellsJ Congleton, R MacDonald, A Yen
Leukemia|December 21, 2011
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortiumA Martino, D Campa, G Buda, et al.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.
Leukemia|March 1, 2012
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxinR Parameswaran, M Yu, M-A Lyu, et al.
Pageof 1,398